JSM Activity #30

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2003 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco
Add To My Program
30 Applied Session Sun, 8/3/03, 2:00 PM - 3:50 PM H-Continental Ballroom 4
Sequential Clinical Trials and Methods - Contributed - Papers
Biopharmaceutical Section
Chair(s): Rajagopalan Srinivasan, Data Specturm Inc.
     2:05 PM   Testing Procedures for Group Sequential Clinical Trials with Multiple Survival Endpoints — Rebecca C. Scherzer, Prosoft Sotware, Inc.
     2:20 PM   Advantages and Disadvantages of Traditional Group Sequential Design and Two Adaptive Design Methodologies — Xiaosha Zhang, Aventis; Min Chen, Aventis Pharmaceuticals, Inc.; Joshua Cantor, Aventis Pharmaceuticals, Inc.
     2:35 PM   Evaluating a Group Sequential Design in the Setting of Nonproportional Hazards — Daniel L. Gillen, University of Washington; Scott S. Emerson, University of Washington
     2:50 PM   Evaluation Criteria for Orderings of Group Sequential Statistics — Bart E. Burington, University of Washington; Scott S. Emerson, University of Washington
     3:05 PM   Exact Moments and Probabilities for the Two-Color Wei's Urn Randomization Model — Neal Oden, EMMES Corporation; Matthew J. McIntosh, The EMMES Corporation
     3:20 PM   Use of a Group Sequential Method for Bioequivalence Testing — Huaixiang Li, Food and Drug Administration; Yi Tsong, Food and Drug Administration
     3:35 PM   Exploratory Data Analysis of a Cancer Clinical Trial — Kao-Tai Tsai, Aventis Pharmaceuticals, Inc.
 

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003